Even with this much larger CRC patient cohort, ZC3H12A expression remains significantly higher in stage I tumors as compared to stage II, or III, or IV tumors, further confirming findings from the original TCGA cohort (Supplementary Figure 3). Here, ZC3H12A is linked to colorectal carcinoma.